Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94249

1.

Development of clinical models for predicting erectile function after localized prostate cancer treatment.

Haskins AE, Han PK, Lucas FL, Bristol I, Hansen M.

Int J Urol. 2014 Jul 23. doi: 10.1111/iju.12566. [Epub ahead of print]

PMID:
25056284
[PubMed - as supplied by publisher]
2.

Upper Limit of Cancer Extent on Biopsy Defining Very Low Risk Prostate Cancer.

Bratt O, Folkvaljon Y, Loeb S, Klotz L, Egevad L, Stattin P.

BJU Int. 2014 Jul 23. doi: 10.1111/bju.12874. [Epub ahead of print]

PMID:
25053197
[PubMed - as supplied by publisher]
3.

Factors influencing the acceptance of transrectal ultrasound-guided prostate biopsies.

Hwang JW, Bang WJ, Oh CY, Yoo C, Cho JS.

Korean J Urol. 2014 Jul;55(7):460-4. doi: 10.4111/kju.2014.55.7.460. Epub 2014 Jul 11.

PMID:
25045444
[PubMed - in process]
Free PMC Article
4.

Sudden loss of vision due to breast cancer metastasis to the eyeball.

Antosz ZS, Walocha J, Poręba R, Sioma-Markowska U.

Neuro Endocrinol Lett. 2014 Jul 20;35(4). [Epub ahead of print]

PMID:
25038605
[PubMed - as supplied by publisher]
5.

Predictive factors of unfavorable prostate cancer in patients who underwent prostatectomy but eligible for active surveillance.

Choo SH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.

Prostate Int. 2014;2(2):70-5. doi: 10.12954/PI.14042. Epub 2014 Jun 30.

PMID:
25032192
[PubMed]
Free PMC Article
6.

Association of the serum vascular endothelial growth factor levels with benign prostate hyperplasia and prostate malignancies.

Sharif MR, Shaabani A, Mahmoudi H, Nikoueinejad H, Akbari H, Einollahi B.

Nephrourol Mon. 2014 Apr 27;6(3):e14778. doi: 10.5812/numonthly.14778. eCollection 2014 May.

PMID:
25032132
[PubMed]
Free PMC Article
7.

Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer.

Sonn GA, Filson CP, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS.

Urol Oncol. 2014 Jul 11. pii: S1078-1439(14)00144-6. doi: 10.1016/j.urolonc.2014.04.003. [Epub ahead of print]

PMID:
25027689
[PubMed - as supplied by publisher]
8.

Mixed primary prostatic carcinoma with acinar, neuroendocrine and ductal components.

Romero-Rojas AE, Diaz-Perez JA, Reddy A.

Arch Ital Urol Androl. 2014 Jun 30;86(2):150-1. doi: 10.4081/aiua.2014.2.150.

PMID:
25017603
[PubMed - in process]
9.

Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program.

Castellano D, Antón Aparicio LM, Esteban E, Sánchez-Hernández A, Germà JR, Batista N, Maroto P, Pérez-Valderrama B, Luque R, Méndez-Vidal MJ; on behalf of the cabazitaxel EAP study.

Expert Opin Drug Saf. 2014 Jul 7:1-9. [Epub ahead of print]

PMID:
25001524
[PubMed - as supplied by publisher]
10.

Attacking an epidemic.

May M.

Sci Am. 2014 Jul;311(1):S4-5. No abstract available.

PMID:
24974698
[PubMed - indexed for MEDLINE]
11.

[Population-based analysis of complications after local therapy for prostate cancer. Prostatectomy versus radiotherapy].

Eble MJ.

Strahlenther Onkol. 2014 Jun;190(6):594-6. German. No abstract available.

PMID:
24967466
[PubMed - indexed for MEDLINE]
12.

Bicalutamide-induced hepatotoxicity: A rare adverse effect.

Hussain S, Haidar A, Bloom RE, Zayouna N, Piper MH, Jafri SM.

Am J Case Rep. 2014 Jun 20;15:266-70. doi: 10.12659/AJCR.890679. eCollection 2014.

PMID:
24967002
[PubMed]
Free PMC Article
13.

Comparison of urinary continence outcome between robotic assisted laparoscopic prostatectomy versus laparoscopic radical prostatectomy.

Asawabharuj K, Ramart P, Nualyong C, Leewansangtong S, Srinualnad S, Taweemonkongsap T, Chaiyaprasithi B, Amornvesukit T, Jitpraphai S, Soontrapa S.

J Med Assoc Thai. 2014 Apr;97(4):393-8.

PMID:
24964681
[PubMed - indexed for MEDLINE]
14.

Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: Prospective standardized analysis of complications.

Van Praet C, Decaestecker K, Fonteyne V, Ost P, De Visschere P, Verschuere S, Rottey S, Lumen N.

Int J Urol. 2014 Jun 25. doi: 10.1111/iju.12534. [Epub ahead of print]

PMID:
24964296
[PubMed - as supplied by publisher]
15.

Shape analysis of the prostate: Establishing imaging specifications for the design of a transurethral imaging device for prostate brachytherapy guidance.

Holmes DR 3rd, Davis BJ, Goulet CC, Wilson TM, Mynderse LA, Furutani KM, Camp JJ, Robb RA.

Brachytherapy. 2014 Jun 21. pii: S1538-4721(14)00540-6. doi: 10.1016/j.brachy.2014.05.013. [Epub ahead of print]

PMID:
24962657
[PubMed - as supplied by publisher]
16.

Ultrasound-planned high-dose-rate prostate brachytherapy: Dose painting to the dominant intraprostatic lesion.

Crook J, Ots A, Gaztañaga M, Schmid M, Araujo C, Hilts M, Batchelar D, Parker B, Bachand F, Milette MP.

Brachytherapy. 2014 Jun 20. pii: S1538-4721(14)00533-9. doi: 10.1016/j.brachy.2014.05.006. [Epub ahead of print]

PMID:
24958556
[PubMed - as supplied by publisher]
17.

The Impact of Robotic Surgery on the Surgical Management of Prostate Cancer in the United States.

Chang SL, Kibel AS, Brooks JD, Chung BI.

BJU Int. 2014 Jun 23. doi: 10.1111/bju.12850. [Epub ahead of print]

PMID:
24958338
[PubMed - as supplied by publisher]
18.

[Correction of erectile dysfunction in patients undergoing radical prostatectomy].

Iudovskiĭ SO, Pushkar' DIu.

Urologiia. 2014 Mar-Apr;(2):66, 68-71. Russian.

PMID:
24956677
[PubMed - indexed for MEDLINE]
19.
20.

A Rare and Unusual Case of Burkitt's Lymphoma Presenting with a Prostate Mass in a 12-Year-Old Boy.

Sinclair N, Babyn P, Kinloch M, Sinha R.

Case Rep Radiol. 2014;2014:106176. doi: 10.1155/2014/106176. Epub 2014 May 13.

PMID:
24955275
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk